Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
NovaBay Pharmaceuticals Inc
NBY
Healthcare
Biotechnology
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSEAM:NBY)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 01, 2024 5:41pm
NovaBay Pharmaceuticals, Inc. (NBY): Laser-Focused on the Lu
https://beyondspx.com/2024/08/01/novabay-pharmaceuticals-inc-nby-laser-focused-on-the-lucrative-dry-eye-market/
(59)
•••
Nibinator
X
Post by
Nibinator
on Nov 15, 2023 5:42pm
Real stock price share value
5.25$
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 09, 2023 4:17pm
New Press Release - NovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
Net product revenue from Avenova®-branded eyecare products grew 7% year-over-year, reflecting an increased contribution from the physician dispensed channelSales and marketing expenses declined 7% versus the prior year through continued optimized digital marketing programsOperating loss for the...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 02, 2023 6:51am
New Press Release - NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and nine months ended September 30, 2023 after market close on Thursday, November 9, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern...
read article.
(59)
•••
Nibinator
X
Post by
Nibinator
on Oct 28, 2023 4:55pm
I m very conservative on that 150%
Looking for 300%
(59)
•••
Nibinator
X
Post by
Nibinator
on Oct 28, 2023 4:52pm
Who wants to make 150 % in 2 weeks
Me
(59)
•••
Nibinator
X
Post by
Nibinator
on Oct 28, 2023 4:50pm
15 november that will hit
0.85 easy
(59)
•••
Nibinator
X
Post by
Nibinator
on Oct 28, 2023 4:41pm
Real stock price share value
12$
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 11, 2023 8:03am
New Press Release - NovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces the launch of two new promotional programs for ophthalmologists and optometrists who help their patients manage the symptoms of chronic...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 02, 2023 6:50am
New Press Release - NovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that Justin Hall, CEO and General Counsel, will present a company overview and hold investor meetings at the 8th Annual Dawson James Small...
read article.
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 22, 2023 1:48pm
NBY.....don't even think about it !!!
I really don't trust this Maddapakka !!!!
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 17, 2023 11:29am
NBY.....a previous pick of mine
Just like FWBI ......I call NBY a "Devil Stock" Tough to make $'s when u have to "scale in" to bring ACB down to where u finally make some dough....I call this "Spear
...more
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 14, 2023 11:28am
NBY....let me re-phrase my last NBY post which....
SH admin removed because of my "Potty Mouth" ...LoL NBY..... more NR's with no follow thru..... Mr. Maggot loves to do this ....you will all be taken to the woodshed for another whoopin
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 14, 2023 8:07am
New Press Release - NovaBay Pharmaceuticals Announces Commercial Launch of Avenova® Allograft
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces the commercial launch of Avenova Allograft to eyecare professionals across the U.S. through its physician-dispensed channel. This prescription product is the only optic allograft manufactured using BioStem Technologies, Inc.’s (OTC...
read article.
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 13, 2023 10:12am
NBY.....All time low !
48 f'king pesos OTC anyone?
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
This company is set to benefit from a change in Ontario legislation
How Web3 Will Fundamentally Reshape Finance